Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001012975-18-000025

President and CEO acquired 183,347 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Enright William · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-01-02 Exercise or conversion : show line 1 in the form +183,347 $0.08 $14,668 364,511 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-02 Exercise or conversion : show line 2 in the form Stock Options (option to buy) −183,347 0 D
Loading xslF345X03/edgar.xml…